Lab members
Lab members
Kexin Zhang, PhD - Postdoc
Mechanisms of therapy resistance and targeted therapy
Pengchao Wang, PhD - Guest Researcher
Modeling therapy resistance in the ovarian cancer mouse models
Leizia Barbieri - Master's Student
Inducible shRNA modulation of PLK1 in syngeneic ovarian cancer mouse models and organoids
Isa Tas, PhD - Assistant Researcher
Understanding the immune microenvironment of cancer and therapy resistance
Wei Tang, PhD - Postdoc
Multi-elemental insights of origin
Lei Zhang, MD - PhD student
Understanding the mechanisms of therapy resistance in ovarian cancer
Maryam Sanjari Pour, PhD - Postdoc
Targeted combination therapy in relapsed T-cell acute lymphoblastic leukemia
Kai Aragaki, PhD - Postdoc
Optimizing machine learning algorithms for cancer detection
Alumni who have contributed to our research over the years.
Postdoctoral Researchers
Ahmad Nasimian, PhD Nov 2021 – Oct 2024 The mechanisms of drug resistance in cancer and the role of BCL2 family proteins.
Mehreen Ahmed, PhD Aug 2020 – Jul 2022 Transcriptional and post-translational regulation of AXL in drug-resistant epithelial ovarian cancer.
Amal Maouia, PhD Jul 2018 – Jun 2019 Deregulation of the cell cycle in acute lymphoblastic leukemia.
Mohiuddin Gazi, PhD Sep 2015 – Aug 2017 PI3K/mTOR pathway dependency in acute lymphoblastic leukemia.
Research Students
Lina Al-Ashiri Jun 2019 – Jan 2020 The transcriptional and post-translational regulation of AXL in drug-resistant epithelial ovarian cancer.
Fatima Khanum Feb 2016 – Jun 2016 Development of targeted therapy against Acute Myeloid Leukemia.
Master's Students
Beatriz Rubio Hombrados Jan 2024 – Jun 2024 Thesis: Targeting FUT8-Driven Core Fucosylation.
Laila Mousafi Alasal Jan 2024 – Jun 2024 Thesis: Estimating Cancer Drug Combination Scores with Minimal Drug Sensitivity Data.
Elham Akbari Asl Mar 2023 - Oct 2023 Thesis: Role of FUT8 in the regulation of cellular signaling in ovarian cancer.
Linn Denison Aug 2022 - Jun 2023 Thesis: Role of PLK1 in the regulation of mitochondrial programmed cell death.
Margaux Oberling Jan 2021 – Jun 2021 Thesis: Temporal regulation of AXL expression in therapy-resistant leukemia.
Hongzhi Duan Nov 2020 - Jun 2021 Thesis: Inhibition of Oncogenic FLT3 Prevents Ferroptosis in Leukemia Cell Models.
Lina Al-Ashiri Jul 2018 – Jun 2019 Thesis: The Role of AXL in Acute Myeloid Leukemia.
Sara Al-Safar Sep 2018 – Jun 2019 Thesis: Identification of Novel Signal Transduction Proteins of Importance for AXL Signaling.
Felix Kronqvist Jul 2018 – May 2019 Thesis: The role of bone marrow stromal cells in therapy resistance of FLT3-ITD positive acute myeloid
leukemia cells.
Kinjal Shah Jun 2016 – Jun 2017 Thesis: Role of the g-protein-coupled receptor p2ry14 in acute leukemia.
Kaja Rupar Jun 2015 – Jun 2016 Thesis: The role of SRC-like adaptor protein 2 (SLAP2) in receptor tyrosine kinase KIT signaling.
Sausan Moharram Feb 2015 – Mar 2016 Thesis: Identification of novel signal transduction proteins of importance for FLT3 signaling in acute
myeloid leukemia.
Bachelor Students
Hanna Barresjö Jan 2018 – May 2018 Thesis: The mutational status of residue Y842 in FLT3 predicts the drug response to acute myeloid leukemia.
Lucy Macaulay Feb 2014 – May 2014 Thesis: Understanding the Mechanisms and specificity of pathway-specific inhibitors in the treatment of
acute myeloid leukemia.